VSVirginia Suaya

Virginia Suaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Virginia Suaya has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Agustin Cabillon

    Ex residente del Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República. Uruguay

    1 shared publication
  • Cecilia Castillo

    Prof. Agregada del Servicio de Oncología. Hospital de Clínicas “Dr. Manuel Quintela”. Facultad de Medicina. Universidad de la República. Montevideo, Uruguay

    1 shared publication
  • Dahiana Amarillo

    Asistente del Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República. Uruguay

    1 shared publication
  • Federico Garcia

    Ex.Prof. Adjunto de la Clínica Médica C, Hospital de Clínicas, Facultad de Medicina, Universidad de la República. Uruguay

    1 shared publication
  • Gabriel Krygier

    Prof. Titular del Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República. Uruguay

    1 shared publication
  • Natalia Camejo

    Prof. Adjunta del Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República. Uruguay

    1 shared publication

Latest Publications

  • Open Access

    Overlap Syndrome of Myocarditis–Myositis– Myasthenia Induced by Immunotherapy in Advanced Melanoma: A Case Report

    by Agustin Cabillon, Natalia Camejo, Dahiana Amarillo, Federico Garcia, Virginia Suaya, Cecilia Castillo, Gabriel Krygier

    Immune checkpoint inhibitors have transformed the treatment of advanced melanoma; however, they may be associated with potentially severe immune-related adverse events. Among these, myocarditis–myositis– myasthenia overlap syndrome (MMM) is a rare but highly life-threatening condition. We report the case of an 84-year-old patient with stage IV melanoma treated with nivolumab and ipilimumab using a reduced-dose regimen, who initially developed immune-mediated hepatitis, followed by proximal muscle weakness, bulbar involvement, and myasthenic symptoms, associated with markedly elevated creatine kinase levels. During hospitalization, the patient developed complete atrioventricular block and significant troponin elevation, consistent with MMM overlap syndrome. Treatment with high-dose intravenous methylprednisolone followed by oral corticosteroids and pyridostigmine was initiated, resulting in favorable clinical evolution, with neurological improvement and hemodynamic stabilization without the need for second-line therapies. This case highlights the importance of early recognition of severe immune- related adverse events, the need for a multidisciplinary approach, and prompt initiation of immunosuppressive therapy, which may significantly improve clinical outcomes even in elderly patients.